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Abstract In developingcountries, many sputum-negative suspects of pulmonary tuberculosis (PTB) are given antitu-
berculousmedication just because tuberculosis (TB) could not be excluded in them.Many studies have shownthat BCG
test is nearly100% sensitive, except in thosewith severemalnutrition, steroid therapy and other causes of immunosup-
pression.The aimofthe present studywas to findouttheproportion of PTB suspects inwhom BCGtestmaybeusefulin
excluding diagnosis of TB.The study was carried out on adult subjects attending District Tuberculosis Clinic (DTC),Pali,
Rajasthan,India.Outof104 subjects studied, all18 sputum-positive subjects showed a positive BCGtest indicating100%
sensitivityof the test.The resultof BCGtest was negative in16.28% of 86 sputum-negative suspects of TB.The BCGtest
did not show any adverse reactions among these cases except for adenitis of axillary or cervical lymph nodes in 6.7%
subjects.The studyraises thepossibility that BCGtestmaybeusefulin excludingdiagnosis oftuberculosisin aproportion
of adult sputum negative-suspects of PTB in developing countries like India.More studies are needed in this direction.
r 2003 Publishedby Elsevier Science Ltd.
doi:10.1053/rmed.2003.1478, available online at http://www.sciencedirect.com
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Subjects having X-ray suggestive of tuberculosis (TB)
and sputum negative for Mycobacterium tuberculosis
(MTB), are considered as suspects of tuberculosis. In
practice antituberculous therapy is given to them. In a
study carried out in China by Hong Kong Chest Service,
Tuberculosis Research Centre,Madras, India, and British
Medical Council, 181 cases with abnormal X-ray and ne-
gative smear and culture forMTB,were notgiven antitu-
berculous therapy and were followed. During follow-up
34%of themdevelopedbacteriologically con¢rmedTB in
12 months (1) and another 7% developed bacteriologi-
cally con¢rmed TB in another 4 years (2). In16% of them
active TB disease was con¢rmed based on radiological
deteriorationwithin 60 months of study.Thus antituber-
culous treatment was given in only 57% of them, in
whom diagnosis of activeTB diseasewas con¢rmed.The
remaining 43% did not require the anti-tuberculous
treatment. In two other studies untreated sputum-nega-
tive suspects of pulmonary tuberculosis were followed
for 5 years, during which only 29^58% of them devel-Received 22 July 2002, accepted in revised form 4 November 2002.
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E-mail: mmmurli@redi¡mail.comoped active bacteriologically con¢rmed tuberculous dis-
ease (3,4). Such studies indicate that more than 40% of
sputum-negative suspects of pulmonary tuberculosis,
may not haveTB disease. In practice they are given anti-
tuberculous therapy, just because diagnosis of TB cannot
be excluded in them. There is no simple and easy test
that can exclude activeTB disease in such suspects.
When BCGvaccine is given to a personwith tubercu-
lous disease, he shows an accelerated reaction. It means
appearance of an indurated area of 5mm ormore in dia-
meter within 24^72 hours of vaccination, formulation of
pustule within 5^7 days, followed by scab formation and
healing in 10^15 days. If the subject is not infected with
tuberculosis the reaction begins to occur only after 2^3
weeks of vaccination. A papule is formed slowly with in-
duration, which develops into pustular stage in 6^8
weeks and a scar or a nodule is formed in 3 months
(5,6).The accelerated reaction to BCGvaccine is known
as positive BCG test. It has been used for diagnosing
tuberculosis in children. Since BCG test has a very high
negative predictive value (7), a negative result of BCG
test in them, may be taken as an indicator of absence of
tuberculous disease. In a country like India where preva-
lence of tuberculous infection is veryhigh, only a few sus-
pects of tuberculosismay show a negative BCG test.The
aim of the present study was to ¢nd out the proportion
of TB suspects in whom BCG test may be useful in ex-
cluding diagnosis of TB.
TABLE 1. Distribution of study subjects according to
their age and sex
Age inyears Males Females Total
No %
15^20 7 12 19 18.3
21^30 14 17 31 29.8
31^40 9 19 28 26.9
41^50 1 8 9 8.7
51^60 3 9 12 11.5
460 0 5 5 4.8
Total 34 70 104 100.0
(32.7%) (67.3%)
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The study subjects were selected from the subjects at-
tending District Tuberculosis Clinic, Pali, Rajasthan, In-
dia. The inclusion criteria were age 15 years or more
and clinical and radiological suspicion of pulmonary
tuberculosis. The exclusion criteria were history of
antituberculous therapy, steroid therapy, known HIV
positive status, severe cachexia, chronic liver/kidney/
heart disease, pregnancy, tuberculous meningitis
and milliary tuberculosis. Their sputum smear stained
with Zeil^Nelson stain was examined microscopically
for acid fast bacilli. Those who gave informed consent
were given 0.1ml BCG vaccine intradermally at the
insertion of deltoid on left arm. The site of injection
was observed after 3 days (72^76h). Any induration
at site of vaccination was measured in millimeters. An
induration of 5 or more millimeters was taken as a
positive BCG test.
RESULTS
One hundred and four adult subjects with clinical and
radiological suspicion of pulmonary tuberculosis were gi-
ven BCG test.Their distribution according to age and sex
is shown inTable1.Eighteen of them showedone ormore
sputum samples positive for acid fast bacilli. All 18 spu-
tum-positive subjects showed a positive BCG Test indi-
cating100% sensitivity of the test (Table 2).The result of
BCG test was negative in 16.28% of 86 sputum-negative
suspects (95% CI=8.5^24.1%).
The relationship between the extension of the radi-
ological features andgrading in the response to BCG test
is depicted in Table 3. Each lung was divided into three
zones upper, middle and lower. All the subjects showing
reaction of 20 ormoremm to BCG, showed radiological
abnormality in two or less lung zones (out of six zones of
two lungs) and all the caseswith radiological abnormality
in three or more zones had less than 20mm reaction to
BCG Test.Total area of opacities in chest X-ray was less
than half of area of left lung in 88 (84.6%) cases and was
more than half area of left lung in16 (15.4%) cases. Mean
reaction to BCGwas13.077.4mmin formergroup,while
itwas 9.074.5mm in latter group, though this di¡erence
was not statistically signi¢cant (t=1.8, P40.05). TheseTABLE 2. Results of BCGtest in cases and suspects of pulmona
Resultof BCGtest Caseswith sputum smear positive for
No. %
Positive 18 100.0
Negative 0 0.0
Total 18 100.0observations indicate that response to BCG test was
smaller in those with larger area of opacities in X-rays.
This needs further con¢rmation.
Out of 23 sputum-negative suspects with a positive
history of BCG vaccination in past, 21 (91.3%) showed a
positive BCG test.While 80.0% of sputum-negative sus-
pects, with no history of BCG vaccination in past,
showedpositive BCG test.The di¡erencewas not signif-
icant (P=0.189).
Fourteen subjects showed negative BCG test
(o5mminduration).Outof them, sevenwere given anti-
tuberculous medication by their treating physicians. Six
out of remaining sevenwhowere not given antitubercu-
lousmedication, were followedby us for 2months.Their
fever had disappeared. Their clinical condition did not
worsen during this period and their physicians did not
start antituberculous medication; though they were gi-
ven antibiotics and symptomatic treatment for cough,
pain, breathlessness, etc. The BCG test did not show
any adverse reaction among study subjects, except for
adenitis of axillary or cervical lymph nodes in 6.7% sub-
jects.
DISCUSSION
In developing countries, a large proportion of cases trea-
ted for pulmonary tuberculosis, are sputum negative.
Not necessarily all of them have tuberculous disease but
they are given antituberculous medication just becausery tuberculosis
AFB Caseswith sputum smearnegative for AFB
No. %
72 83.7
14 16.3
86 100.0
TABLE 3. Relationship between extension of radiological lesions andresponse to BCGtest
Response of BCGtest (induration inmm) No. of lung zones showingradiological abnormality
One Two Three Four Five Six Total
No. %
0^4 8 3 0 0 2 1 14 13.4
5^9 8 5 2 1 0 1 17 16.3
10^14 14 15 5 0 0 2 36 34.6
15^19 6 5 4 0 0 1 16 15.4
20^24 8 5 0 0 0 0 13 12.5
25^29 3 1 0 0 0 0 4 3.9
30+ 1 3 0 0 0 0 4 3.9
Total No. 48 37 11 1 2 5 104
% 46.1 35.6 10.6 1.0 1.9 4.8 100.0
530 RESPIRATORYMEDICINEdiagnosis of tuberculosis could not be excluded in them.
There is a felt and unmet need for a test, which may be
used to exclude diagnosis of TB in such suspects.The fact
that tuberculin test has been found to be negative in sig-
ni¢cant proportion of cases of tuberculosis (8^12), indi-
cates that a negative tuberculin reaction cannot be used
to exclude diagnosis of TB.There is no ideal test, which
can diagnose all the cases of TB.Transcription mediated
nucleic acid ampli¢cation for direct demonstration of
Mycobacterium tuberculosis from sputum, considered to
be the most sensitive has 93.6^98.4% sensitivity (13^16).
It requires a sophisticated laboratory and a skilled tech-
nician. It is not presently a¡ordable by TB patients of
mostcountries.Chandra etal. (17) gave BCG test to eight
adults having sputum-positive pulmonary tuberculosis
andgotpositive result in all of them, indicating100% sen-
sitivity of the test. Sonmezet al. (18) found BCG test po-
sitive in 39 out of 40 adult cases of pulmonary
tuberculosis, though diagnosis of tuberculosis was not
bacteriologically con¢rmed in all of them.We also found
BCG test positive in100% cases of pulmonary tuberculo-
sis. A limitation of the present study is that tuberculosis
was not con¢rmed by sputum culture for MTB/MOTT
(Mycobacteria other than tuberculosis) in smear positive
cases. Here microscopic examination of sputum of 18
subjectswas positive for acid fastbacilli, inwhomculture
could have con¢rmed presence of MTB or MOTT but
it could not be done because of lack of facility for
di¡erentiating MTB from MOTT using culture. Most
studies in India have shown a very low prevalence of
MOTT in sputum samples (19^22). MOTT is more com-
mon in HIV positive cases and we had speci¢cally ex-
cluded HIV positive cases from present study. Thus
probability of having cases of MOTTamong 18 sputum-
positive cases in present study is therefore quite less.
Since all the18 sputum-positive subjects in present study,
showed a positive BCG test, it can safely be assumed
that all those showing MTB in sputum were positive to
BCG test.In children,Gocmen et al. (8),Velhaletal. (23) andUda-
ni et al. (24) have found BCG test 100% sensitive in con-
¢rmed cases of tuberculosis. This high sensitivity of the
test raises possibility of its use to exclude diagnosis of tu-
berculosis. However, some studies in children have
shown a lower sensitivity of BCG test, but these had in-
cluded cases of tuberculosis which were not bacteriolo-
gically con¢rmed (25^33). Secondly, cases of severe
malnutrition, anergy, tuberculous meningitis and immu-
nosuppresion were also included in these studies, which
are likely to show a negative BCG test. Inspite of high
sensitivity, BCG test is not speci¢c for tuberculous dis-
ease, as it is also found positive in subjects infected with
MTB but not su¡ering from the tuberculous disease.
Lack of speci¢city keeps this test useless in diagnosing
TB, but possibility of use of its high negative predictive
value in excludingTB, was assessed in the present study.
The results showed that 16.3% of sputum-negative sus-
pects of pulmonary tuberculosis were negative to BCG
test, this raises the possibility that BCG testmaybe use-
ful in excluding diagnosis of tuberculosis in this propor-
tion of adult sputum negative suspects of PTB in
developing countries like India. Sensitivity and utility of
tuberculin test has already been reported to be much
lower than BCG test, bymany authors (8,17^18, 23^36).
Comparison of BCG test with tuberculin test was not
aimed at and tuberculin test was therefore not included
in the present study.
Chandra etal. (17) foundno adversereaction of BCGin
bacteriologically con¢rmed adult cases of TB. Somez
et al. also did not ¢nd any adverse reactions to BCG test
in adult cases of pulmonary tuberculosis.Udani et al. (24)
and Jaiswaletal. (29) foundno adversereaction of BCGon
course of tuberculous disease in children.Udani et al (24)
found7%childrendevelopedlymphadenopathy,whichwas
not serious.Gocmen et al. (8) found no complications due
to BCGvaccination in proved TB cases. Dikshit et al. (32)
did not observe much of side e¡ects. Bhandari et al. (25)
showed that 1^2% subjects developed subcutaneous
UTILITYOFBCGTEST INEXCLUDINGTUBERCULOSIS 531abscess, which was due to subcutaneous injection of vac-
cine and couldbe avoidedbycarefully injecting it intrader-
mally, as super¢cially as possible. They did not ¢nd any
complication in childrenwith other acute conditions. Even
amongHIV infected subjects, six cohort studies have indi-
cated that theremay be only small increased risk of com-
plications following BCG vaccination, but the reactions
are usuallymild and the risk does not outweigh the bene-
¢ts of BCGvaccination inpopulations athighriskof tuber-
culosis (37).Use of BCG vaccine has been recommended
and safely used in children irrespective of their state of in-
fection in India. BCG vaccination of adults is also recom-
mended (38). In present study the BCG test did not
show any adverse reactions except for adenitis of axillary
or cervical lymph nodes in 6.7% subjects.
It can therefore be concluded that BCG test is a safe
tool, with a very high level of sensitivity. Present study
has raised possibility of its use to exclude diagnosis of tu-
berculous disease in adult suspects.More studies are re-
quired in this direction to prove this hypothesis.
However, the BCG test also has some limitations. It will
be of no use in cases with tuberculousmeningitis, severe
malnutrition, steroid therapy, HIV infection and other
causes of immunosuppressioin. At the same time carry-
ing out BCG test in all TB suspectswill givephysical trau-
ma of vaccination and a scar of the same to them. In
developing countries,more than 60% casesbeing treated
for tuberculosis, are sputum negative (39). If BCG test
can excludeTB in 16% of them, it may reduce the con-
sumption of antituberculous medicines to a large extent
inNational Tuberculosis Control Programmes.The ques-
tion may be of particular interest when Directly Ob-
served Therapy (DOT) is used, which costs more and
requires more intensive e¡orts on part of healthcare
worker aswell aspatient.From thepatient’sperspective,
if BCG test can exclude diagnosis of TB in some of them,
long-term antituberculousmedication and its side e¡ects
can be avoided in them. If diagnosis of TB is excluded, pa-
tient is also saved from psychological stress of bearing
social stigma of TB.
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